Showing results (311-320 of 385) with videos related to
Sort By:
Pageof 39
American Journal of Clinical and Experimental Urology|June 13, 2015
Clear cell sarcoma of the penis: a case reportTimothy Ito, Jonathan Melamed, Mary Ann Perle, et al.American Journal of Clinical and Experimental Urology|June 13, 2015
Combination of 5α-reductase inhibitor with combined androgen blockade (CAB) as a novel cytoreductive regimen before prostate brachytherapy: Ultra-CABYusuke Muro, Takeo Kosaka, Ryuichi Mizuno, et al.American Journal of Clinical and Experimental Urology|April 19, 2018
The structure of the nucleus in normal and neoplastic prostate cells: untangling the role of type 2 DNA topoisomerasesWilliam G Nelson, Michael C Haffner, Srinivasan YegnasubramanianAmerican Journal of Clinical and Experimental Urology|November 7, 2014
Splicing variants of androgen receptor in prostate cancerHaitao Zhang, Yang Zhan, Xichun Liu, et al.American Journal of Clinical and Experimental Urology|November 7, 2014
Mini-review: androgen receptor phosphorylation in prostate cancerGarrett Daniels, Zhiheng Pei, Susan K Logan, et al.American Journal of Clinical and Experimental Urology|November 7, 2014
Active surveillance in men with low-risk prostate cancer: current and future challengesChristopher Sejong Han, Jaspreet Singh Parihar, Isaac Yi KimAmerican Journal of Clinical and Experimental Urology|November 7, 2014
Cytoskeleton targeting value in prostate cancer treatmentSarah K Martin, Marisa Kamelgarn, Natasha KyprianouAmerican Journal of Clinical and Experimental Urology|November 7, 2014
Androgen receptor coactivators that inhibit prostate cancer growthGarrett Daniels, Ruchi Jha, Ying Shen, et al.American Journal of Clinical and Experimental Urology|November 7, 2014
Glomerular sparing pattern in primary kidney neoplasms: clinical, morphological and immunohistochemical studyFaisal M Huq Ronny, Judy Sarungbam, Xuelin Zhong, et al.American Journal of Clinical and Experimental Urology|November 7, 2014
Growth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasterideRaquel Ramos Garcia, Khalid Z Masoodi, Laura E Pascal, et al.Pageof 39